SOLUTIONS AS UNIQUE AS YOUR NEEDS

Specialty Services







Home Site Map Contact Us Search
 
 
 

What's New

December 5, 2007

The Impact of Medicare Reimbursement Changes on Hematology/Oncology Practices

In late 2006, the Centers for Medicare & Medicaid Services (CMS) finalized the much-anticipated 2007 Physician Fee Schedule (PFS), which included two major changes that affected reimbursement.  These Medicare PFS changes have several distinct implications for compensation planning and reimbursement for hematology/oncology practices.  On November 1, 2007, CMS released the 2008 PFS final rule.  This article assesses the impact of these reimbursement changes.

 
 
 

Cancer Programs

Cancer programs and service lines are at the forefront of healthcare change in this country.  While the population ages and the incidence of people with cancer rises, legislative changes have decreased hospital and physician payments for cancer therapies.  Patients are becoming more intelligent consumers who choose hospitals and physicians based on reputation, supportive services, access to advanced treatments, and high-quality care.  To be successful in this environment, hospital and physician organizations need to:

  • Proactively manage within the complex and ever-changing clinical reimbursement environment.
  • Look for ways to creatively affiliate or joint venture with one another to increase market share and achieve some economies of scale.
  • Develop a more coordinated, customer-focused delivery model, such as tumor-site specific programs or full-service cancer centers, that will benefit both patients and providers.
  • Create a patient care model that is both efficient and cost-effective utilizing the appropriate mix of physicians and mid-level providers.
  • Implement a physician model that maximizes efforts in the patient care, bench research, translational research, and clinical research areas.
  • Ensure that a majority of their research effort is funded (through the National Cancer Institute [NCI] and well balanced clinical trials program).

Our clients have benefited from a variety of cancer-related services, including:

  • Cancer service line strategic/business planning and implementation.
  • Creation of joint ventures and other affiliation options.
  • Review of research structures and the financial performance of clinical trials.
  • Development of physician productivity metrics.
  • Implementing multidisciplinary clinics and creating comprehensive cancer programs

Examples of our experience in this area include:

 
 

Selected Projects

  • Developing strategic and business plans for a comprehensive cancer center.
  • Developing an NCI-designated cancer center.
  • Evaluating options for developing business relationships between health systems and medical groups.
  • Negotiating affiliation agreements between physician practices and hospitals.

Related Links

   
 

Next Webinar:
Friday, May 16
 Learn More
 Register Now